What is Dr. Zubair Khalid's research focus?

Dr. Zubair Khalid specializes in molecular virology, mRNA vaccine development, and computational biology, with a focus on avian pathogens like IBDV and Avian Reovirus.

Where is Dr. Zubair Khalid currently working?

Dr. Zubair Khalid is a Postdoctoral Research Associate at the University of Maryland (UMD), specifically within the Department of Animal and Avian Sciences.

Mammalian Cell Culture Bioreactors: A Practical Guide

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-11

Introduction to Mammalian Cell Culture Bioreactors

A mammalian cell culture bioreactor is a controlled environment vessel designed to support the growth and maintenance of mammalian cells for the production of biopharmaceuticals, vaccines, gene therapy vectors, and cell-based therapeutics. Unlike microbial bioreactors, which cultivate bacteria or yeast at high cell densities in simple, defined media, mammalian cell bioreactors must accommodate the unique physiological requirements of eukaryotic cells: slower growth rates, greater shear sensitivity, complex nutritional demands, and a narrow window of tolerable osmotic and pH conditions.

The purpose of a mammalian bioreactor extends beyond simply holding cells in suspension. It must deliver oxygen, maintain homogeneous mixing, regulate temperature and pH, and provide a means to add nutrients and remove waste—all while minimizing mechanical stress on cells that lack the protective cell wall found in prokaryotes. The operational paradigm differs fundamentally from microbial systems: mammalian cells typically grow at 37°C, require a dissolved oxygen concentration of 30–50% air saturation, and are cultivated at lower cell densities (10–30 × 10⁶ cells/mL in fed-batch, up to 100 × 10⁶ cells/mL in perfusion) compared to the 100–200 g/L dry cell weight achievable with E. coli.

What is a mammalian cell culture bioreactor?

A mammalian cell culture bioreactor is a vessel—constructed from glass, stainless steel, or single-use polymers—equipped with systems for agitation, aeration, temperature control, and process monitoring. The core function is to maintain a homogeneous environment in which cells receive consistent access to nutrients and oxygen while metabolic waste products are diluted or removed. The vessel is typically jacketed for temperature control, fitted with a sparger for gas delivery, and agitated by an impeller or rocking motion to keep cells suspended.

The key distinction from microbial bioreactors lies in the engineering solutions required to accommodate mammalian cell fragility. Microbial bioreactors operate at high agitation speeds (500–1000 rpm) and high airflow rates (1–2 vvm, volumes of air per volume of liquid per minute) to achieve the high oxygen transfer rates demanded by fast-growing bacteria. Mammalian cells, by contrast, have no cell wall and are 10–20 µm in diameter, making them vulnerable to hydrodynamic damage. Consequently, mammalian bioreactors use lower agitation speeds (50–200 rpm), gentler impeller geometries, and oxygen-enriched air or pure oxygen sparging to meet oxygen demand without excessive shear.

Why use mammalian cells for biopharmaceutical production?

Mammalian cells are the preferred expression system for complex therapeutic proteins—monoclonal antibodies, cytokines, clotting factors, and fusion proteins—because they perform post-translational modifications that are critical for protein function. The most important of these is glycosylation: the enzymatic attachment of oligosaccharide chains to asparagine (N-linked) or serine/threonine (O-linked) residues. The specific glycan structures added by mammalian cells, particularly the absence of the immunogenic α-1,3-galactose epitope and the presence of sialic acid residues, are essential for proper protein folding, serum half-life, and reduced immunogenicity in humans.

Chinese hamster ovary (CHO) cells are the workhorse cell line, accounting for approximately 70% of all recombinant therapeutic proteins approved by regulatory agencies. CHO cells grow well in suspension, adapt readily to serum-free media, and can be genetically engineered to produce high titers of secreted proteins—current fed-batch processes routinely achieve 5–10 g/L of monoclonal antibody. Other commonly used lines include HEK293 cells for transient protein production and viral vector manufacturing, and NS0 or Sp2/0 murine myeloma cells for antibody production. For a broader overview of cell culture fundamentals, see Give a Brief Introduction About Cell Culture.

Key Design Features and Configurations

The selection of a bioreactor configuration is driven by the cell line, the product, the scale of production, and the intended culture mode. Three main configurations dominate mammalian cell culture: stirred-tank bioreactors, wave-induced motion bioreactors, and hollow-fiber bioreactors.

Stirred-tank bioreactors

Stirred-tank bioreactors (STRs) are the industry standard for large-scale mammalian cell culture. They consist of a cylindrical vessel with a centrally mounted or off-center impeller, a sparger for gas introduction, and baffles to improve mixing. The working volume ranges from 1 L in development to 20,000 L in commercial manufacturing. The design principles are well established, and the extensive body of engineering knowledge makes scale-up predictable.

The vessel geometry follows a standard aspect ratio of height-to-diameter of 2:1 to 3:1. The impeller is typically a pitched-blade or marine-type impeller that generates axial flow, which is gentler than the radial flow produced by Rushton turbines used in microbial systems. Axial flow pushes fluid downward, creating a circulation pattern that suspends cells with lower shear stress. The sparger is usually a microsparger or frit with pore sizes of 10–50 µm, producing small bubbles that enhance oxygen transfer. In large vessels, a second, larger sparger may be used for CO₂ stripping.

Single-use vs. stainless steel

Single-use bioreactors (SUBs) use pre-sterilized plastic bags or rigid plastic vessels that are discarded after a single campaign. They eliminate the need for cleaning-in-place (CIP) and sterilization-in-place (SIP), reducing turnaround time between batches from days to hours and eliminating the risk of cross-contamination. SUBs are available in volumes from 50 L to 2,000 L, with the upper limit constrained by the mechanical strength of the polymer film and the practical limitations of bag handling.

Stainless steel bioreactors remain the choice for very large-scale production (>2,000 L) and for processes requiring organic solvents or extreme pH conditions that degrade single-use polymers. They offer superior heat transfer, higher pressure ratings, and longer service life. The capital cost is significantly higher, but for established products with long lifecycles, the total cost of ownership may favor stainless steel. Many facilities adopt a hybrid approach: single-use for seed trains and early production stages, stainless steel for final production.

Impeller design and shear stress considerations

Impeller design is the single most important factor determining the hydrodynamic environment experienced by mammalian cells. The goal is to achieve adequate mixing and oxygen transfer while keeping shear stress below the threshold that damages cells. The relevant metric is the Kolmogorov eddy length scale, which describes the size of the smallest turbulent eddies in the flow. When eddies approach the size of a cell (10–20 µm), the energy dissipated in the eddy can deform and rupture the cell membrane.

Pitched-blade impellers (typically 2–3 blades at a 30–45° pitch) generate axial flow with lower energy dissipation rates than radial-flow Rushton turbines. The power input per unit volume (P/V) is typically maintained at 20–80 W/m³ for mammalian cells, compared to 1,000–5,000 W/m³ for microbial cultures. The tip speed, which correlates with maximum shear stress, is kept below 2 m/s. In addition to impeller geometry, shear damage can be mitigated by the addition of shear-protective agents such as Pluronic F-68 (a nonionic surfactant) at 0.5–1 g/L, which stabilizes the cell membrane and reduces cell–bubble interactions.

Operating Parameters and Control Strategies

Mammalian cells have narrow tolerances for environmental parameters. The control strategy must maintain these parameters within tight setpoints while responding to the changing metabolic demands of the culture as cell density increases.

pH control and CO₂ sparging

The optimal pH for most mammalian cell lines is 7.0–7.2, with a typical control deadband of ±0.05–0.1 pH units. pH is controlled by two complementary mechanisms: CO₂ sparging and base addition. CO₂ dissolves in the culture medium to form carbonic acid, which dissociates to bicarbonate and hydrogen ions, lowering pH. Conversely, CO₂ stripping by sparging with air or oxygen removes CO₂, raising pH. Base addition—typically 1–2 M sodium hydroxide or sodium bicarbonate—provides rapid upward pH correction.

The bicarbonate buffering system is the primary physiological buffer in mammalian cell culture media, operating at a pKa of 6.1. Media are typically formulated with 2–4 g/L sodium bicarbonate and maintained under a CO₂ atmosphere of 5–10% to hold pH near 7.2. As cells metabolize glucose and glutamine, they produce CO₂ and lactic acid, which acidify the culture. The control system responds by increasing base addition and reducing CO₂ sparging. In high-density cultures, lactate accumulation can overwhelm the buffering capacity, requiring the addition of higher concentrations of base or the use of alternative buffers such as HEPES (10–25 mM) in research-scale cultures.

Dissolved oxygen and oxygen transfer

Mammalian cells require dissolved oxygen (DO) concentrations of 30–50% of air saturation. Below 10–20%, cells shift to anaerobic metabolism, increasing lactate production and reducing growth. Above 80–100%, oxygen toxicity can occur due to the generation of reactive oxygen species. DO is controlled by adjusting the oxygen concentration in the sparge gas, the sparging rate, and, to a lesser extent, the agitation speed.

The oxygen transfer rate (OTR) is governed by the volumetric mass transfer coefficient (kLa), which quantifies the efficiency of oxygen transfer from the gas to the liquid phase. The kLa depends on the gas flow rate, bubble size, agitation speed, and medium composition. For mammalian cells, the oxygen demand is relatively low—typically 0.1–0.5 mmol O₂/L/h at peak cell density—but the low solubility of oxygen in water (approximately 0.2 mM at 37°C under air) means that continuous sparging is required. In high-density perfusion cultures, pure oxygen is often blended with air to meet demand without increasing gas flow rates to levels that cause foaming or shear damage.

Temperature and shear stress management

Temperature is maintained at 36.5–37.5°C for most cell lines, with a control accuracy of ±0.1–0.2°C. The vessel jacket circulates water or uses an electric heating blanket. Temperature control is straightforward, but deviations can have significant consequences: a drop to 33–35°C is sometimes used deliberately in "cold-shock" strategies to slow growth and enhance productivity in fed-batch processes.

Shear stress management is an integrated design consideration rather than a single control parameter. It involves the selection of impeller geometry and speed, sparger design, and the use of protective additives. The critical shear stress for mammalian cells is typically in the range of 1–10 Pa, depending on the cell line and the duration of exposure. Cells in suspension are less sensitive to shear than attached cells, but they are vulnerable to damage at gas–liquid interfaces—bubble rupture at the surface is a major cause of cell death. This is mitigated by using microspargers to produce small bubbles, adding Pluronic F-68, and maintaining a headspace pressure that reduces bubble size.

Culture Modes: Batch, Fed-Batch, Perfusion

The choice of culture mode determines the productivity, complexity, and cost of a biopharmaceutical process. Three modes are used in mammalian cell culture: batch, fed-batch, and perfusion.

Batch culture

In batch culture, all nutrients are added at the start of the process, and the culture is harvested at the end without any further additions. The cell density increases until a nutrient is depleted or a toxic byproduct accumulates, at which point the culture declines. Batch culture is simple, requires minimal operator intervention, and has a low risk of contamination. However, productivity is limited by the initial nutrient concentration, and the accumulation of lactate and ammonia typically restricts maximum cell densities to 2–5 × 10⁶ cells/mL.

Batch culture is rarely used for commercial production of recombinant proteins, but it remains useful for inoculum preparation, media development, and small-scale studies where simplicity is valued over productivity.

Fed-batch culture

Fed-batch culture is the dominant mode for commercial monoclonal antibody production. The process begins as a batch, but concentrated nutrient feeds are added periodically or continuously during the growth phase. This extends the culture duration (typically 10–21 days), increases the maximum cell density to 10–30 × 10⁶ cells/mL, and achieves product titers of 5–10 g/L.

The feeding strategy is designed to maintain nutrient concentrations above limiting levels while minimizing the accumulation of metabolic waste. Glucose is typically maintained at 2–6 g/L, and glutamine at 2–6 mM, by feeding concentrated solutions. The feed composition is often a proprietary formulation containing amino acids, vitamins, trace elements, and growth factors. Fed-batch processes are operated in a controlled environment with daily or continuous monitoring of cell density, viability, and metabolite concentrations. The advantages are high product concentration, relatively simple operation, and compatibility with existing downstream processing equipment. The disadvantages are the accumulation of lactate and ammonia, which eventually limit culture duration, and the need for careful process optimization.

Perfusion culture

Perfusion culture involves the continuous addition of fresh medium and the simultaneous removal of spent medium while retaining cells in the bioreactor. This is achieved using cell retention devices such as alternating tangential flow (ATF) filters, tangential flow filtration (TFF) modules, or acoustic settlers. Perfusion supports very high cell densities (50–100 × 10⁶ cells/mL) and extends culture duration to 30–60 days or longer.

The advantages of perfusion are high volumetric productivity, consistent product quality due to short residence time in the bioreactor, and the ability to operate at steady state. The disadvantages are increased complexity, higher risk of filter fouling, greater medium consumption, and the need for continuous monitoring and control. Perfusion is used for products that are unstable in the culture environment, for cell lines that are sensitive to byproduct accumulation, and for continuous manufacturing processes. It is also the preferred mode for the production of labile products such as clotting factors and some viral vectors.

A comparison of the three modes is summarized in Table 1.

Parameter	Batch	Fed-Batch	Perfusion
Maximum cell density (×10⁶/mL)	2–5	10–30	50–100
Culture duration (days)	5–10	10–21	30–60+
Product titer (g/L)	0.1–0.5	5–10	1–5 (continuous)
Medium consumption	Low	Moderate	High
Operational complexity	Low	Moderate	High
Risk of contamination	Low	Moderate	High
Typical application	Inoculum, R&D	Monoclonal antibodies	Labile products, continuous manufacturing

Media and Feeding Strategies

The design of culture media and feeding strategies is central to achieving high cell densities and product titers. Mammalian cells have complex nutritional requirements that must be met by a combination of basal medium and concentrated feeds.

Basal media and supplements

Basal media for mammalian cell culture are formulated to provide all essential nutrients: amino acids, vitamins, inorganic salts, glucose, and a buffering system. The most widely used formulations are DMEM (Dulbecco's Modified Eagle's Medium), RPMI-1640, and Ham's F-12, but these are often supplemented or replaced by proprietary serum-free media designed for specific cell lines.

Serum, historically added at 5–10% (v/v), provides growth factors, hormones, lipids, and transport proteins. However, serum introduces batch-to-batch variability, risks of contamination with adventitious agents, and regulatory concerns. Modern biopharmaceutical production uses serum-free media, which are supplemented with recombinant growth factors (e.g., insulin at 5–10 mg/L, transferrin at 5–10 mg/L), lipids (e.g., cholesterol, fatty acids), and hydrolysates of plant or yeast origin. The development of chemically defined media, in which every component is known and quantified, is the current standard for regulatory approval.

Fed-batch feeding strategies

Fed-batch feeding strategies are designed to deliver nutrients at rates that match cellular demand, avoiding both nutrient limitation and excessive accumulation of byproducts. Two broad approaches are used: fixed-schedule feeding and dynamic feeding.

Fixed-schedule feeding involves adding a predetermined volume of concentrated feed at set time intervals (e.g., every 24–48 hours). The feed volume is calculated based on the expected cell growth curve and the nutrient consumption rates. This approach is simple and robust but does not account for batch-to-batch variability in cell growth.

Dynamic feeding uses online or at-line measurements of glucose, lactate, or cell density to adjust the feed rate in real time. For example, glucose can be maintained at a setpoint of 3 g/L by a peristaltic pump controlled by an online glucose analyzer. This approach improves consistency and can increase productivity by 10–30% compared to fixed-schedule feeding, but it requires reliable online sensors and more sophisticated control algorithms.

Metabolic waste management

Lactate and ammonia are the two major metabolic byproducts that limit cell growth and productivity. Lactate is produced from glucose via glycolysis and from glutamine via glutaminolysis. In the early exponential phase, cells produce lactate at a high rate (the "lactate-producing" phase), but many cell lines shift to a "lactate-consuming" phase as the culture progresses, where they take up lactate and use it as a carbon source. Ammonia is produced primarily from glutamine metabolism and from the spontaneous deamination of glutamine in the medium.

Lactate concentrations above 2–4 g/L inhibit cell growth and can reduce product quality by altering glycosylation. Ammonia concentrations above 2–4 mM are toxic, affecting intracellular pH and nucleotide metabolism. Strategies to manage these byproducts include:

Reducing glutamine in the medium and replacing it with glutamate or pyruvate, which produce less ammonia.
Controlling glucose concentration at low levels (1–3 g/L) to reduce lactate production.
Using cell lines with reduced lactate dehydrogenase (LDHA) expression or with enhanced capacity for lactate consumption.
Adding copper sulfate (0.5–1 µM), which has been shown to promote the metabolic shift from lactate production to consumption in some CHO cell lines.
Using perfusion mode to continuously remove lactate and ammonia from the culture.

Scale-Up and Scale-Down Considerations

Scaling up a mammalian cell culture process from laboratory to production scale is a critical and challenging step. The goal is to maintain equivalent cell growth, productivity, and product quality across scales, which requires careful consideration of mixing, oxygen transfer, and shear stress.

Scale-up criteria

The most common scale-up criterion is maintaining a constant power input per unit volume (P/V). This ensures that the mixing time and the energy dissipation rate remain similar across scales. However, as the vessel volume increases, the impeller tip speed increases for a given P/V, which can increase shear stress. An alternative criterion is constant impeller tip speed, which maintains a similar maximum shear stress but results in longer mixing times at larger scales.

A practical scale-up strategy is to maintain P/V constant while adjusting the impeller design to keep the tip speed below 2 m/s. The gas flow rate is scaled based on the oxygen demand, which is proportional to the cell density and the culture volume. The kLa must be sufficient to meet the oxygen demand, which may require the use of oxygen-enriched air or pure oxygen at large scales where the gas flow rate is limited by foaming and shear considerations.

Table 2 provides typical scale-up parameters for a stirred-tank bioreactor.

Parameter	2 L (lab)	200 L (pilot)	2,000 L (production)	20,000 L (production)
Working volume (L)	1.5	150	1,500	15,000
Vessel height/diameter	2:1	2:1	2.5:1	3:1
Impeller type	Pitched-blade	Pitched-blade	Pitched-blade	Pitched-blade
P/V (W/m³)	50	50	50	50
Tip speed (m/s)	0.8	1.2	1.6	1.9
Gas flow rate (vvm)	0.1	0.05	0.02	0.01
kLa (1/h)	10–20	8–15	5–10	3–6

Scale-down models for process development

Scale-down models are small-scale systems (typically 1–10 L) that mimic the environment of a large-scale bioreactor. They are used for process development, optimization, and troubleshooting without the cost and time required for large-scale experiments. The key is to reproduce the critical process parameters—pH, DO, temperature, and nutrient concentrations—while also simulating the mixing time, shear stress, and CO₂ stripping characteristics of the production scale.

A common scale-down approach is the use of multiple small bioreactors operated in parallel with automated control systems. These systems can reproduce the pH and DO dynamics of a large-scale process, including the spatial gradients in pH and DO that occur in large vessels due to imperfect mixing. For example, a scale-down model might use a slow base addition rate to simulate the pH gradient that cells experience near the base addition point in a 20,000 L vessel. This allows researchers to evaluate the impact of process parameters on product quality and to develop control strategies that are robust to scale-related variability.

Monitoring and Process Analytical Technology (PAT)

Process Analytical Technology (PAT) is a regulatory framework that encourages the use of real-time measurements to design, analyze, and control manufacturing processes. In mammalian cell culture, PAT enables tighter control of critical process parameters and provides a basis for continuous process verification and quality-by-design (QbD) approaches.

In-situ sensors

In-situ sensors are inserted directly into the bioreactor and provide continuous, real-time measurements. The most common are:

pH electrodes: Glass or optical sensors that measure pH with an accuracy of ±0.02 pH units. Optical sensors use a fluorescent dye whose emission spectrum shifts with pH.
Dissolved oxygen probes: Optical sensors based on fluorescence quenching by oxygen, or amperometric (Clark-type) electrodes. Optical sensors are preferred for single-use bioreactors because they are pre-calibrated and disposable.
Temperature probes: Resistance temperature detectors (RTDs) or thermocouples with an accuracy of ±0.1°C.
Capacitance probes: Measure the viable cell density by detecting the capacitance of intact cell membranes. This provides a real-time, non-invasive measurement of viable biomass, which is valuable for controlling feeding strategies.

Raman spectroscopy and other PAT tools

Raman spectroscopy is a powerful PAT tool that provides real-time, multi-analyte measurements from a single probe. Raman scattering is inelastic scattering of light that produces a spectrum characteristic of the molecular composition of the sample. In cell culture, Raman spectroscopy can simultaneously measure glucose, lactate, glutamine, glutamate, ammonia, and cell density, as well as product titer in some cases. The spectra are analyzed using multivariate calibration models that are developed from historical data.

The advantages of Raman spectroscopy are its ability to measure multiple analytes simultaneously, its non-invasive nature (the probe is inserted into the bioreactor but does not consume sample), and its compatibility with both glass and single-use bioreactors. The limitations are the complexity of the calibration models, the sensitivity to environmental factors such as temperature and bubbles, and the relatively high cost of the instrumentation.

Other PAT tools include:

At-line analyzers: Automated sampling systems that withdraw a sample from the bioreactor and analyze it using HPLC, enzymatic assays, or flow cytometry. These provide more detailed measurements than in-situ sensors but with a time delay of 5–30 minutes.
Dielectric spectroscopy: Measures the capacitance and conductance of the culture, providing information on cell density, cell size, and membrane integrity.
Mass spectrometry: Used for off-gas analysis to measure oxygen uptake rate (OUR) and carbon dioxide evolution rate (CER), which are indicators of metabolic activity.

Common Pitfalls and Troubleshooting

Despite careful design and control, mammalian cell culture processes can fail. The most common issues are contamination, foaming, and low productivity, each with characteristic causes and solutions.

Contamination prevention

Contamination is the most feared event in cell culture because it can destroy a batch and compromise the entire facility. The sources are:

Microbial contamination (bacteria, yeast, fungi): Typically introduced through improper aseptic technique, contaminated media, or leaks in the bioreactor. Prevention requires rigorous training, sterile filtration of all additions, and regular validation of the sterilization process.
Mycoplasma contamination: Mycoplasmas are small bacteria that lack a cell wall and are resistant to many antibiotics. They are difficult to detect and can persist in cultures without visible signs. Detection requires specific PCR-based assays or culture methods. Prevention relies on using mycoplasma-free cell lines and testing all new cell lines before introduction to the facility.
Viral contamination: Introduced through raw materials of animal origin (e.g., serum) or through the cell line itself. Prevention involves using serum-free media, viral inactivation steps, and testing of cell banks.

If contamination is detected, the affected culture should be immediately autoclaved and discarded. The bioreactor must be thoroughly cleaned and sterilized, and the source of contamination must be identified through a root-cause analysis before resuming production.

Foaming and cell damage

Foaming is a common problem in aerated bioreactors, particularly at high gas flow rates or in media with high protein content. Foam can cause cell damage when bubbles burst at the liquid surface, and it can block exhaust filters, leading to pressure buildup. The solutions are:

Reduce gas flow rates and use oxygen-enriched air to meet oxygen demand with less gas.
Use antifoam agents such as polydimethylsiloxane (PDMS) or polypropylene glycol (PPG) at concentrations of 0.01–0.1% (v/v). Antifoam should be added sparingly because it can interfere with oxygen transfer and downstream processing.
Use a mechanical foam breaker that disperses foam by centrifugal force.
Increase the headspace height to allow foam to collapse naturally.

Low productivity troubleshooting

Low product titer can result from many factors, and a systematic approach is required to identify the root cause. The first step is to review the process data: cell growth, viability, metabolite concentrations, and product titer over time. Common causes and solutions are:

Nutrient limitation: Check glucose, glutamine, and amino acid concentrations. If any are below the target range, adjust the feeding strategy.
Byproduct accumulation: High lactate or ammonia levels can inhibit productivity. Consider reducing glucose or glutamine concentrations, or switching to perfusion mode.
Suboptimal pH or DO: Review the process logs to ensure that pH and DO were maintained within the target ranges. Even brief excursions can affect productivity.
Genetic instability: Cell lines can lose productivity over time due to genetic drift. If productivity declines over multiple passages, thaw a new vial from the working cell bank.
Product degradation: Proteases released by dying cells can degrade the product. If viability drops significantly, harvest the culture earlier or add protease inhibitors.

Frequently Asked Questions

What is the best bioreactor for mammalian cell culture?

The stirred-tank bioreactor is the best choice for most applications because it offers the most predictable scale-up, the widest range of operating volumes, and the most mature engineering knowledge. For small-scale process development and for products with limited production volumes, single-use stirred-tank bioreactors offer flexibility and reduced risk of cross-contamination. Wave-induced motion bioreactors are suitable for seed train expansion and for shear-sensitive cell types, but they are less well characterized for large-scale production. Hollow-fiber bioreactors are niche tools used primarily for the production of labile products at small scale or for cell-based therapies.

How do you control pH in a mammalian cell bioreactor?

pH is controlled by a combination of CO₂ sparging and base addition. CO₂ dissolves to form carbonic acid, lowering pH, while sparging with air or oxygen strips CO₂, raising pH. A base solution (typically 1–2 M NaOH or sodium bicarbonate) is added to raise pH when it falls below the setpoint. The control system uses a PID (proportional-integral-derivative) controller that adjusts the CO₂ flow rate and base addition rate to maintain pH within a deadband of ±0.05–0.1 units around the setpoint of 7.0–7.2.

What is the difference between fed-batch and perfusion culture?

In fed-batch culture, nutrients are added periodically or continuously, but the culture volume increases and nothing is removed until harvest. The product accumulates in the bioreactor, and the culture is harvested after 10–21 days. In perfusion culture, fresh medium is added continuously and spent medium is removed continuously while cells are retained in the bioreactor. Perfusion supports higher cell densities and longer culture durations, and the product is harvested continuously. Fed-batch is simpler and more common for monoclonal antibody production, while perfusion is used for labile products and continuous manufacturing.

Why is shear stress a concern in mammalian cell culture?

Mammalian cells lack a cell wall and are 10–20 µm in diameter, making them vulnerable to hydrodynamic forces. High shear stress can damage the cell membrane, leading to cell death or reduced productivity. The most damaging forces are those generated at gas–liquid interfaces, such as bubble rupture at the surface, and those from turbulent eddies that are similar in size to the cells. Shear stress is managed by using gentle impeller designs (pitched-blade rather than Rushton), low agitation speeds, microspargers, and shear-protective additives like Pluronic F-68.

How do you scale up a mammalian cell culture bioreactor?

The most common scale-up criterion is constant power input per unit volume (P/V). This maintains similar mixing and energy dissipation rates across scales. The impeller tip speed must be kept below 2 m/s to avoid excessive shear stress, and the gas flow rate is scaled to meet the oxygen demand of the culture. Scale-down models are used to develop and validate the process at small scale before committing to production-scale runs.

What are common causes of low cell viability in a bioreactor?

Low cell viability can result from nutrient depletion, toxic byproduct accumulation (lactate, ammonia), suboptimal pH or temperature, oxygen limitation, shear stress, or contamination. A systematic review of the process data—cell density, metabolite concentrations, and environmental parameters—is the first step in identifying the cause. Adjusting the feeding strategy, improving the control of pH and DO, or switching to perfusion mode are common solutions.

What is the role of dissolved oxygen in mammalian cell culture?

Dissolved oxygen is the substrate for oxidative phosphorylation, the primary energy-generating pathway in mammalian cells. The optimal DO concentration is 30–50% of air saturation. Below this range, cells shift to anaerobic metabolism, producing more lactate and reducing growth. Above this range, oxygen toxicity can occur due to the generation of reactive oxygen species. DO is controlled by adjusting the oxygen concentration in the sparge gas and the gas flow rate.

Key Takeaways

Mammalian cell culture bioreactors are engineered to accommodate the shear sensitivity, slow growth, and complex nutritional needs of eukaryotic cells, distinguishing them fundamentally from microbial systems.
Stirred-tank bioreactors, particularly in single-use formats, are the industry standard; impeller design and power input are the primary levers for managing shear stress.
pH, dissolved oxygen, and temperature must be controlled within narrow ranges; the bicarbonate–CO₂ buffering system is central to pH control.
Fed-batch is the dominant mode for monoclonal antibody production, while perfusion enables higher cell densities and continuous processing for labile products.
Media design and feeding strategies must balance nutrient supply against the accumulation of lactate and ammonia, which are the primary metabolic inhibitors.
Scale-up is guided by constant power per unit volume, with careful attention to tip speed, mixing time, and oxygen transfer; scale-down models are essential for process development.
PAT tools, including Raman spectroscopy and capacitance probes, enable real-time monitoring and control, supporting quality-by-design and continuous manufacturing.
Contamination, foaming, and low productivity are the most common process failures, each with well-established prevention and troubleshooting strategies.